GeneDx Holdings Corp (NAS:WGS)
$ 96.57 -0.47 (-0.48%) Market Cap: 2.65 Bil Enterprise Value: 2.65 Bil PE Ratio: 0 PB Ratio: 12.96 GF Score: 43/100

Sema4 Holdings Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 16, 2022 / 04:20PM GMT
Release Date Price: $47.52 (-0.69%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. Welcome, everybody. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs, and I'm pleased to be hosting Sema4 today at our conference. We've got Katherine Stueland, the Chief Executive Officer; and Joel Kaufman, Vice President of Finance and Corporate Development. Katherine, Joel, thanks for joining us.

Katherine A. Stueland
Sema4 Holdings Corp. - CEO & Director

Thank you for having us.

Joel Harrison Kaufman
Sema4 Holdings Corp. - VP of Finance & Corporate Development

Thank you for having us.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if we could just kind of start out, you can kind of set the stage for us a little bit and talk about some of the recent changes, there's been many, and sort of your expectations for the course of this year and some of the key

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot